Showing results (201-210 of 956) with videos related to
Sort By:
Pageof 96
Annals of General Psychiatry|March 9, 2010
Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptorsTsutomu Furuse, Kenji HashimotoPsychiatry Investigation|January 30, 2014
Benefical effects of sigma-1 agonist fluvoxamine for tardive dyskinesia and tardive akathisia in patients with schizophrenia: report of three casesYakup Albayrak, Kenji HashimotoAsian Journal of Psychiatry|October 4, 2024
Therapeutic potential of ketamine in management of epilepsy: Clinical implications and mechanistic insightsYunfei Tan, Kenji HashimotoEuropean Archives of Psychiatry and Clinical Neuroscience|August 3, 2016
Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depressionYukihiko Shirayama, Kenji HashimotoCurrent Pharmaceutical Design|March 2, 2011
α7 nicotinic acetylcholine receptor as a potential therapeutic target for schizophreniaMasatomo Ishikawa, Kenji HashimotoPlos One|December 15, 2010
A novel target of action of minocycline in NGF-induced neurite outgrowth in PC12 cells: translation initiation [corrected] factor eIF4AIKenji Hashimoto, Tamaki IshimaBrain Tumor Pathology|August 12, 2011
Anaplastic ependymoma simulating glioblastoma in the cerebrum of an adultMasayuki Shintaku, Kenji HashimotoPlos One|June 2, 2012
Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by ifenprodil: the role of sigma-1 and IP3 receptorsTamaki Ishima, Kenji HashimotoAnnals of General Psychiatry|December 23, 2009
Fluvoxamine monotherapy for psychotic depression: the potential role of sigma-1 receptorsTsutomu Furuse, Kenji HashimotoPageof 96